SETD2: from chromatin modifier to multipronged regulator of the genome and beyond
TM Molenaar, F van Leeuwen - Cellular and Molecular Life Sciences, 2022 - Springer
Histone modifying enzymes play critical roles in many key cellular processes and are
appealing proteins for targeting by small molecules in disease. However, while the functions …
appealing proteins for targeting by small molecules in disease. However, while the functions …
Using ubiquitin binders to decipher the ubiquitin code
Post-translational modifications (PTMs) by ubiquitin (Ub) are versatile, highly dynamic, and
involved in nearly all aspects of eukaryote biological function. The reversibility and …
involved in nearly all aspects of eukaryote biological function. The reversibility and …
[HTML][HTML] Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription
L Kollenstart, AJL de Groot, GMC Janssen… - Journal of Biological …, 2019 - Elsevier
Histone post-translational modifications (PTMs) are critical for processes such as
transcription. The more notable among these are the nonacetyl histone lysine acylation …
transcription. The more notable among these are the nonacetyl histone lysine acylation …
Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation
Aims Abdominal aortic aneurysm (AAA) is a common, serious vascular disease with no
effective pharmacological treatment. The nucleoside adenosine plays an important role in …
effective pharmacological treatment. The nucleoside adenosine plays an important role in …
Nucleosome and ubiquitin position Set2 to methylate H3K36
S Bilokapic, M Halic - Nature Communications, 2019 - nature.com
Histone H3 lysine 36 methylation (H3K36me) is a conserved histone modification deposited
by the Set2 methyltransferases. Recent findings show that over-expression or mutation of …
by the Set2 methyltransferases. Recent findings show that over-expression or mutation of …
Histone methylation in DNA repair and clinical practice: new findings during the past 5-years
S Wei, C Li, Z Yin, J Wen, H Meng, L Xue… - Journal of …, 2018 - pmc.ncbi.nlm.nih.gov
DNA double-strand breaks (DSBs) are highly toxic lesions that can impair cellular
homeostasis and genome stability to result in tumorigenesis for inappropriate repair …
homeostasis and genome stability to result in tumorigenesis for inappropriate repair …
[HTML][HTML] The chromatin landscape around DNA double-strand breaks in yeast and its influence on DNA repair pathway choice
C Frigerio, E Di Nisio, M Galli, CV Colombo… - International Journal of …, 2023 - mdpi.com
DNA double-strand breaks (DSBs) are harmful DNA lesions, which elicit catastrophic
consequences for genome stability if not properly repaired. DSBs can be repaired by either …
consequences for genome stability if not properly repaired. DSBs can be repaired by either …
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells
EM Kwesi-Maliepaard, MA Aslam… - Proceedings of the …, 2020 - pnas.org
Cytotoxic T cell differentiation is guided by epigenome adaptations, but how epigenetic
mechanisms control lymphocyte development has not been well defined. Here we show that …
mechanisms control lymphocyte development has not been well defined. Here we show that …
Replication-IDentifier links epigenetic and metabolic pathways to the replication stress response
Perturbation of DNA replication, for instance by hydroxyurea-dependent dNTP exhaustion,
often leads to stalling or collapse of replication forks. This triggers a replication stress …
often leads to stalling or collapse of replication forks. This triggers a replication stress …
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
Abstract DOT 1L methylates histone H3K79 and is aberrantly regulated in MLL‐rearranged
leukemia. Inhibitors have been developed to target DOT 1L activity in leukemia, but cellular …
leukemia. Inhibitors have been developed to target DOT 1L activity in leukemia, but cellular …